Showing 1,801 - 1,820 results of 39,497 for search '(( 5 ((non decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.02s Refine Results
  1. 1801
  2. 1802
  3. 1803
  4. 1804
  5. 1805
  6. 1806
  7. 1807
  8. 1808

    Light spectrum modifies the utilization pattern of energy sources in <i>Pseudomonas</i> sp. DR 5-09 by Samareh Gharaie (4710206)

    Published 2017
    “…<div><p>Despite the overruling impact of light in the phyllosphere, little is known regarding the influence of light spectra on non-phototrophic bacteria colonizing the leaf surface. …”
  9. 1809

    S2 File - by Ekaterina Khristenko (17847064)

    Published 2024
    “…It was found more frequently in males (42 out of 56; 75%) than in females (37 out of 61; 60.6%). Additionally, we observed a decrease in muscle mass (hidden sarcopenia) in 79.7% in patients with a normal BMI. …”
  10. 1810

    S1 File - by Ekaterina Khristenko (17847064)

    Published 2024
    “…It was found more frequently in males (42 out of 56; 75%) than in females (37 out of 61; 60.6%). Additionally, we observed a decrease in muscle mass (hidden sarcopenia) in 79.7% in patients with a normal BMI. …”
  11. 1811
  12. 1812

    Comparative analysis of SMI in two groups. by Ekaterina Khristenko (17847064)

    Published 2024
    “…It was found more frequently in males (42 out of 56; 75%) than in females (37 out of 61; 60.6%). Additionally, we observed a decrease in muscle mass (hidden sarcopenia) in 79.7% in patients with a normal BMI. …”
  13. 1813
  14. 1814

    Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma by Zhihao Liu (419349)

    Published 2024
    “…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …”
  15. 1815

    Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma by Zhihao Liu (419349)

    Published 2024
    “…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …”
  16. 1816

    Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma by Zhihao Liu (419349)

    Published 2024
    “…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …”
  17. 1817
  18. 1818
  19. 1819
  20. 1820